Provided by Tiger Trade Technology Pte. Ltd.

Aytu BioScience, Inc.

2.55
+0.08003.24%
Post-market: 2.47-0.0800-3.14%18:45 EST
Volume:134.46K
Turnover:338.48K
Market Cap:25.98M
PE:-1.33
High:2.60
Open:2.49
Low:2.44
Close:2.47
52wk High:2.82
52wk Low:0.9500
Shares:10.19M
Float Shares:5.69M
Volume Ratio:0.70
T/O Rate:2.36%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.9179
EPS(LYR):-2.1596
ROE:-50.23%
ROA:0.61%
PB:1.12
PE(LYR):-1.18

Loading ...

Aytu BioPharma, Inc. (NASDAQ:AYTU) Stock Catapults 28% Though Its Price And Business Still Lag The Industry

Simply Wall St.
·
Yesterday

Aytu Biopharma Inc. held annual shareholder meeting

Reuters
·
Dec 11

Aytu BioPharma Is Maintained at Buy by Ascendiant Capital

Dow Jones
·
Dec 10

Aytu BioPharma Presents at Noble Capital Markets Emerging Growth Equity Conference

Reuters
·
Nov 25

Aytu Biopharma Unveils Strategic Focus on CNS Therapeutics and EXXUA Launch in Latest Corporate Presentation

Reuters
·
Nov 19

Aytu BioScience (AYTU) Gets a Buy from Lake Street

TIPRANKS
·
Nov 14

Aytu BioPharma Q1 revenue beats expectations

Reuters
·
Nov 14

Aytu Biopharma Q1 Revenue USD 13.888 Million

THOMSON REUTERS
·
Nov 14

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Nov 12

Aytu BioPharma Secures Patent Extension for EXXUA Through 2030

Reuters
·
Oct 28

Aytu Biopharma Inc. Announces Date for Upcoming Annual Stockholders Meeting

Reuters
·
Oct 25

Aytu Biopharma Inc. Publishes Corporate Presentation Highlighting Focus on CNS Therapeutics and Strategic Growth Initiatives

Reuters
·
Oct 14

Aytu Biopharma Inc to Participate in Planet MicroCap Showcase Toronto 2025

Reuters
·
Oct 10

Aytu BioPharma Is Maintained at Buy by Ascendiant Capital

Dow Jones
·
Sep 25

Aytu BioPharma Loses US$2.3m Market Value But Insiders See Windfall Of US$58k

Simply Wall St.
·
Sep 25

Aytu BioPharma price target lowered to $7 from $9 at Maxim

TIPRANKS
·
Sep 25

Aytu BioPharma Unveils Strategy Targeting $22 Billion Major Depressive Disorder Market

Deep News
·
Sep 24

Aytu BioScience (AYTU) Receives a Buy from Lake Street

TIPRANKS
·
Sep 24

Stocks to Watch: Aytu BioPharma, Cohu, Cyclerion

Dow Jones
·
Sep 24

Aytu BioPharma Q4 EPS $(2.92) Misses $(0.04) Estimate, Sales $15.135M Miss $17.922M Estimate

Benzinga
·
Sep 24